This Is ‘Half-Reform’ On Covid-19 Vaccines. Fairly Regulate Monopoly Power
Half-knowledge, say the wise, is dangerous. Half-reform, say I, is equally destructive. Unfortunately, that's what the government's new vaccination regimen is, a ‘half-reform'.
On the plus side, scrapping an unviable price cap is spot on. This will allow manufacturers to get a productive ‘return on capital' and is the only spur to new investments in enhancing capacity. No coercion or fiat will get entrepreneurs to put money on a losing proposition. Period.

But ‘free pricing' is only a ‘half-reform'. Which is why, despite being the correct way to go, the government is encountering a tidal wave of criticism, for being ‘hasty', ‘half-baked', and ‘capitulating before big capital'. In fact, here is the distilled missive from Sonia Gandhi to Prime Minister Modi (I have excerpted relevant sentences):
The policy implies that the Government of India has abdicated its responsibility to provide free vaccination for citizens between the age group of 18 to 45 years. As a consequence of this policy, the vaccine manufacturer, i.e., the Serum Institute of India announced a differential pricing mechanism today, viz., Rs. 150/- per dose for the Central Government, Rs. 400/- per dose for State Government and Rs. 600/- per dose for Private Hospitals. This means that citizens will be compelled to pay these high rates to be vaccinated. This will also bleed the finances of State Governments.
This begs the question, how can the same vaccine manufactured by the same company have three different prices? There is no rationale or justification that allows for such arbitrary distinction. Even with regards to the fifty percent quota for vaccination available with the Central Government, the allocation must be transparent and equitable, in line with the spirit of cooperative federalism.
Government Hits Back At ‘Free Market Liberals'
Stung by a similar blowback from academicians and experts, the government is hitting out, especially at ‘free-market liberals and intelligentsia' who have been relentlessly campaigning for these changes. “Now that we've done what you guys have been asking for, you've flipped and become critical. That's unfair!”, is the refrain one hears from government sources.
Is that correct? Are people like me (aka ‘free market liberals') now condemning the government for doing exactly what we had been pushing for? No, that's not quite correct. I applaud the fact that the state has relaxed its stranglehold on prices. I also cheer throwing open our market to foreign producers. Both actions will augment supplies. But is that it? Was there nothing more to be done?
The government defends itself, asking “what else was possible?”, thereby betraying an age-old blind spot, that is, our rulers equate free markets with laissez-faire. In fact, this equation captures the contempt they have for free markets. They have never understood – nay, they are not willing to understand – that free markets are as opposed to laissez-faire as Milton Friedman is to Karl Marx.
Free markets are competitive, transparently regulated, creating a level playing field for producers and consumers. Laissez-faire, on the other hand, is chaotic, exploitative, and abusive.
To think of free markets as being equal to laissez-faire is to broadcast your illiteracy to the world.
New Vaccine Policy is More Laissez-Faire Than Free Markets
Why have I taken this tiny tutorial on laissez-faire? Because by freeing only Covid-19 vaccine prices, without defining collateral regulation, the Modi government has propagated laissez-faire and has not created a free/competitive market for vaccines.
Remember, the current market structure is akin to a ‘monopolistic utility' – that is, there is one producer who dominates 90% of the market, and since the vaccine is a product that is critical to life, that producer can abuse his monopoly power. Imagine what would happen if a single water or electricity distributor (water and electricity being critical to life) could whimsically charge any price or deny any connection to any consumer? For example, he could ask me to pay Rs 100/litre while giving it free to my neighbour; he could even slap a 100-litre cap on my household while giving away gallons to my entitled neighbour. We would be living in a jungle, right? This is why monopoly power/pricing must be regulated fairly, not left unfettered.
Regulate The Vaccine Market Like A ‘Monopolistic Utility'
So, until several other vaccines have entered India, and Serum Institute's market share has fallen to about 30-40%, we cannot not regulate the vaccine market like a ‘monopolistic utility'. Transparent rules will have to be crafted to ensure fairness:
- How will limited vaccine supplies be apportioned among competing states? Clearly, all supplies cannot simply be given to a cash-rich state that is willing to pay upfront. The rights of poorer states will have to be equitably protected.
- How will supplies be apportioned between states and private hospital chains? Since Serum will be making an extra profit of 50% on hospital supplies, there is a severe conflict/bias that needs to be curbed. A formula will have to be mandated so that states are not starved of their legitimate claims.
- Since the central government is commandeering 50% of the output at a heavily discounted price, it should be bound by an equitable allocation algorithm. The central government should not be allowed to give a ‘higher than deserved allocation' to some states at the expense of others, because that will create a financial burden on the excluded states. The losing state would be put back by Rs 250 cr for every consignment of one crore doses that the central government ‘knowingly misallocates'
I guess by now you've got what I mean when I say that the new rules on ‘free pricing' of vaccines are a potentially destructive half-reform.
Unless a cogent framework is simultaneously created to curb monopoly power and ensure fair distribution among states and private hospitals, we are staring at chaos and abuse.
The ball is squarely in the Modi government's court.
In the federal spirit, it should set up a Vaccination Council (on the lines of the GST Council) so that its actions are fair, and more importantly, seen to be fair.
Raghav Bahl is Co-Founder – The Quint Group including BloombergQuint. He is the author of three books, viz ‘Superpower?: The Amazing Race Between China's Hare and India's Tortoise', ‘Super Economies: America, India, China & The Future Of The World', and ‘Super Century: What India Must Do to Rise by 2050'.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.